Axiora Medical
Axiora Medical
Explore our clinical-grade orthopedic solution catalogue engineered to meet international regulatory standards and OEM/ODM specifications.
The global foot and ankle reconstruction market is experiencing a profound paradigm shift. Historically dominated by triple arthrodesis (joint fusion), contemporary orthopedics is witnessing an accelerating adoption of Total Ankle Arthroplasty (TAA) and variable-angle anatomic locking fixation systems. This shift is driven by clinical evidence demonstrating preserved joint kinematics, reduced adjacent-segment osteoarthritis, and enhanced patient mobility post-intervention.
Information Gain Insight: According to clinical registry data and market statistics, the global total ankle replacement market is projected to expand at a CAGR of 7.8% through 2030. High-volume hospital procurement programs are increasingly favoring integrated suppliers capable of delivering biocompatible implant hardware alongside patient-specific instrumentation (PSI) and robust OEM/ODM manufacturing compliance.
Transition from traditional rigid joint fusion toward motion-preserving endoprostheses. Modern third- and fourth-generation ankle implants replicate complex talocrural joint biomechanics, minimizing shear stress on adjacent subtalar and talonavicular joints.
Deployment of advanced medical titanium alloys (Ti-6Al-4V ELI grade according to ASTM F136 / ISO 5832-3), Trabecular Titanium structures, and Ultra-High-Molecular-Weight Polyethylene (UHMWPE) inserts with Vitamin E stabilization to eliminate polyethylene wear debris.
Global medical device brand owners require contract manufacturers capable of providing end-to-end traceability, high-precision Swiss-type turning, 5-axis CNC milling, ISO Class 7 cleanroom aseptic packaging, and CE/FDA regulatory audit support.
Designing total ankle systems presents unique engineering challenges compared to hip or knee prostheses due to the small joint surface area, high peak force loads (up to 5 times body weight during normal gait), and delicate soft-tissue envelope surrounding the distal tibia and talus.
Modern distal tibial components feature low-profile stem geometries or porous-coated pegs designed for press-fit primary stability. Titanium Plasma Spray (TPS) and Hydroxyapatite (HA) dual coatings encourage rapid osseointegration, preventing aseptic loosening—the leading cause of mid-to-long term implant revision.
The talar component must replicate the natural truncated cone shape of the talar dome. Advanced manufacturing processes utilize 5-axis synchronous milling and robotic mirror polishing to achieve surface roughness ($R_a$) under 0.02 microns, dramatically reducing friction against the bearing liner.
Understanding the clinical trade-offs between dynamic unconstrained mobile-bearing liners (popular in European protocols) and fixed-bearing two-component designs (widely approved under US FDA pathways).
Combining TAA with variable-angle anatomic fibula locking plates and elastic syndesmotic dynamic fixation devices to maintain lateral ankle complex stability.
High-precision resection guides, intramedullary/extramedullary alignment towers, and trial components engineered from surgical grade 17-4PH stainless steel.
Axiora Medical Technology (China) Co., Ltd. is a premier professional manufacturer specializing in the research, development, production, and global supply of high-quality orthopedic implants and surgical instruments. Our product portfolio covers trauma fixation systems, spinal implants, joint reconstruction solutions, sports medicine products, and related orthopedic surgical instruments.
Established with a commitment to innovation and precision manufacturing, Axiora integrates advanced CNC machining, automated production lines, and strict quality management systems to deliver reliable products that meet international standards. Our experienced engineering team continuously develops innovative solutions to support surgeons and healthcare providers worldwide. With strong OEM and ODM capabilities, we provide customized manufacturing services according to customers' drawings, samples, and technical requirements.
| Item / Parameter | Details & Operational Specifications |
|---|---|
| Company Name | Axiora Medical Technology (China) Co., Ltd. |
| Brand | Axiora |
| Website | www.axioraortho.com |
| Established Year | 2017 |
| Factory Footprint Area | 18,600 m² Modernized Manufacturing Facility |
| Annual Export Revenue | USD 26 Million |
| Export Experience | 8 Years Direct Global Exporting |
| Industry Experience | 15 Years Dedicated Medical Device R&D and Production |
| Quality Inspection Protocols | 100% Finished Product Inspection & Incoming Material Inspection (Zero Defect Goal) |
| Product Inspection Methods | Coordinate Measuring Machine (CMM), Tensile Testing, Hardness Testing, Surface Roughness Inspection, Salt Spray Corrosion Testing |
| Quality Control Staff | 48 Full-Time Quality Assurance & Control Engineers |
| Business Type | Manufacturer & Exporter (Comprehensive OEM / ODM Solutions) |
| Main Export Markets | Europe, North America, Middle East, Southeast Asia, South America, Africa |
| Supply Chain Partners | 1,120 Qualified OEM Brand Partners & Medical Distributors |
| Main Customer Types | Medical Device Brands, Importers, Distributors, Hospitals, Government Procurement Projects |
| R&D Capability | Independent Product Development, Reverse Engineering, OEM & ODM Solutions |
| Customization Options | Logo Laser Printing, Private Labeling, Custom Packaging, Product Design, Material Selection, Drawing-Based Manufacturing |
| New Products Released Last Year | 126 Certified Orthopedic Hardware & Tool Systems |
| R&D Engineering Staff | 86 Senior Biomedical & Mechanical Engineers |
Every medical device produced at Axiora passes through rigorous multi-stage quality gates, ensuring uncompromised mechanical performance, bio-compatibility, and surface integrity.
Medical device importers, regional healthcare distributors, and hospital procurement boards face stringent compliance standards, inventory cost constraints, and product reliability risks. Axiora acts as a strategic manufacturing partner providing integrated solutions for OEM/ODM clients globally.
By streamlining our 18,600 m² vertical integration facility—from titanium rod cutting to sterile packaging—we reduce client procurement costs by 25-35% without sacrificing precision tolerance (±0.005mm).
Full technical documentation support for regulatory dossier submissions (EU MDR 2017/745, US FDA 510(k), ISO 13485:2016 quality system audit certification, and full batch material heat-number traceability).
Dual-source raw material contracts (Titanium Grade 5 ELI, Stainless Steel 316L, PEEK-OPTIMA), buffer safety stock agreements, and agile tooling setup for dynamic demand spikes.
Expanding orthopedic brand reach requires nuanced understanding of local clinical practices and regulatory environments across North America, Europe, Latin America, the Middle East, and Asia-Pacific.
We provide full white-label and private-label customization programs tailored to local market specifications:
Navigating international regulatory frameworks with dedicated regulatory affairs experts:
As additive manufacturing and artificial intelligence intersect with joint arthroplasty, Axiora's R&D division is driving innovations across four key technology vectors:
Utilizing Electron Beam Melting (EBM) and Direct Metal Laser Sintering (DMLS) to fabricate custom talar replacement components for complex revision cases involving severe bone loss or avascular necrosis of the talus.
Integrating micro-electronic telemetry sensors into trial implants and definitive wear liners to monitor real-time joint reaction forces, gait biomechanics, and post-operative infection via local temperature variations.
Developing transient syndesmotic fixation screws and osteotomy pins manufactured from bioresorbable magnesium-zinc-calcium alloys, eliminating the clinical need for secondary hardware removal surgery.
Deploying machine-learning algorithms to process patient CT scans, automatically calculating joint mechanical axes and recommending pre-contoured locking plate geometry and resection depth.
Complete your global orthopedic procurement portfolio with our certified trauma, spine, joint, and veterinary surgical lines.
